The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tregs, gMDSCs, and levels of soluble MICA as prognostic biomarkers for combined NEO-201 and pembrolizumab.
 
Jamie Hur
No Relationships to Disclose
 
Massimo Fantini
Employment - Precision Biologics
Research Funding - Precision Bilogics, Inc.
Patents, Royalties, Other Intellectual Property - Precision Biologics
 
Kwong Y. Tsang
Employment - Precision Biologics
Leadership - Precision Biologics
Research Funding - Precision Biologics
Patents, Royalties, Other Intellectual Property - Precision Biologics
 
Kevin Conlon
No Relationships to Disclose
 
Charalampos S. Floudas
No Relationships to Disclose
 
Azam Ghafoor
No Relationships to Disclose
 
Anjum Zaki
Employment - Precision Biologics
 
Sharon Mavroukakis
Employment - Precision Biologics
 
Ann McCoy
No Relationships to Disclose
 
Christine Feierabend
No Relationships to Disclose
 
Erica Redmond
No Relationships to Disclose
 
Philip M. Arlen
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Patents, Royalties, Other Intellectual Property - Precision Biologics
 
Christina M. Annunziata
Research Funding - Astex Pharmaceuticals (Inst); Precision Biologics (Inst)
Patents, Royalties, Other Intellectual Property - MaxCyte (Inst); Precision Biologics (Inst)